% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • capitalpreservation1 capitalpreservation1 Dec 13, 2012 10:08 PM Flag

    Brean Starts SNTA at Buy

    Brean Murray began coverage on shares of Synta Pharmaceuticals Corp. (NASDAQ: SNTA) in a research note issued to investors on Thursday. The firm issued a buy rating and a $12.00 target price on the stock.
    Several other analysts have also recently commented on the stock. Analysts at Jefferies Group raised their price target on shares of Synta Pharmaceuticals Corp. from $15.00 to $22.00 in a research note to investors on Monday, October 1st. They now have a buy rating on the stock.

0.193+0.006(+3.21%)Feb 12 4:00 PMEST